Why cancer care is personal for us Why cancer care is personal for us At Boehringer Ingelheim, we have made a generational commitment to transforming cancer care, with the ultimate goal of curing a range of cancers.
Investigational Compound Granted FDA Orphan Drug Designation Investigational Compound Granted FDA Orphan Drug Designation U.S. FDA Grants Orphan Drug Designation to Investigational Compound for Idiopathic Pulmonary Fibrosis
Shelter Revamps Make for Strong Bonds, More Adoptions Shelter Revamps Make for Strong Bonds, More Adoptions Shelter Revamps Make for Strong Bonds, More Adoptions
Consumer Health Data Privacy Consumer Health Data Privacy This Consumer Health Data Privacy Policy applies to “Consumer Health Data,” as that term has been defined under applicable law.
Newsletter Duplicate subscription error Newsletter Duplicate subscription error Newsletter Duplicate subscription error
Animal Health: Our Responsibility Animal Health: Our Responsibility BI's commitment to animal health is reflected in our more than 100 years of successful company history. It is also at the core of sustainability.
Dirk Stenkamp Dirk Stenkamp Dirk Stenkamp, Senior Vice President Research Site Germany, reflects on our culture of collaboration and passion for progress.
Edda Dankmeyer Edda Dankmeyer Edda Dankmeyer leads Sustainable Development Communications and explains how sustainable development can bea key differentiator for the company.
Galym Zhunisbekov Galym Zhunisbekov Galym Zhunisbekov, a Regional Regulatory Affairs Manager in Eastern Europe, talks about our philosophy and impact on patients’ lives.
Oncology Partnering Interests | Boehringer Ingelheim US Oncology Partnering Interests | Boehringer Ingelheim US Click here to view our range of downloads on Boehringer Ingelheim's oncology & cancer immunology partnering interests.
Our Retinal Health Partnering Interests Our Retinal Health Partnering Interests Our Retinal Health Partnering Interests
Partnering Interests in CardioMetabolic Diseases Partnering Interests in CardioMetabolic Diseases Partnering Interests in CardioMetabolic Diseases
BIPI Post Marketing Requirements PDF | Boehringer Ingelheim US BIPI Post Marketing Requirements PDF | Boehringer Ingelheim US
More Green | Sustainable Development | Boehringer Ingelheim US More Green | Sustainable Development | Boehringer Ingelheim US Our MORE GREEN pillar encompasses initiatives that consider many different aspects: adopting measures to avoid water and air pollution, & much more.
Work Care Consortium | COVID-19 | Boehringer Ingelheim US Work Care Consortium | COVID-19 | Boehringer Ingelheim US Click here to read more on Boehringer Ingelheim's work with the CARE Consortium in dealing with the COVID-19 pandemic.
Animal Health | COVID-19 | Boehringer Ingelheim US Animal Health | COVID-19 | Boehringer Ingelheim US Click here to read more on how the COVID-19 pandemic has impacted the daily lives of veterinarians, livestock producers and others.
Corporate Social Responsibility | Boehringer Ingelheim US Corporate Social Responsibility | Boehringer Ingelheim US Boehringer Ingelheim has a strong and longstanding commitment to improving the health of people and animals, both around the world and in local communities.